Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Transcripts
    • AGM Invitations
    • IPOs
  • inderesTV
  • Forum
  • Discovery
  • About Us
    • Our Coverage
    • Team

Oncopeptides

1.39 SEK

+0.07 %

Less than 1K followers

ONCO

NASDAQ Stockholm

Biotechnology & Pharmaceuticals

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data

Income statement

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Oncopeptides

2019202020212022202320242025
Revenue118.38.435.231.771.1
growth-%-92.9 %321.3 %-10.1 %124.7 %
EBITDA-739.4-1,591.3-1,420.9-349.4-253.5-283.5-
EBIT-739.4-1,591.3-1,420.9-349.4-253.5-283.5-224.7
Profit before taxes-739.9-1,592.4-1,421.4-337.7-248.5-284.2-248.2
Net income-740.7-1,594.7-1,430.3-338.0-249.1-284.6-249.6
EPS-9.08-16.21-12.04-2.61-1.75-1.52-1.04
Dividend0.000.000.000.000.000.000.00
Dividend ratio-0.0 %-0.0 %-0.0 %-0.0 %-0.0 %-0.0 %-0.0 %

Profitability and return on capital

2019202020212022202320242025
EBITDA-%-1,201.2 %-4,178.8 %-719.6 %-895.7 %
EBIT-%-1,201.2 %-4,178.8 %-719.6 %-895.7 %-315.9 %
ROE-92.9 %-276.4 %-678.3 %-114.8 %-438.7 %-524.2 %423.8 %
ROI-74.6 %-168.4 %-325.5 %-87.7 %-104.5 %-116.6 %-185.1 %
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.